Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic pulmonary vascular remodeling

MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic... J Mol Med (2017) 95:977–993 DOI 10.1007/s00109-017-1541-5 ORIGINAL ARTICLE MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic pulmonary vascular remodeling 1 2 2 2 2 Cui Ma & Chen Zhang & Mingfei Ma & Lixin Zhang & Linlin Zhang & 2 1 3 4 4 Fengying Zhang & Yingli Chen & Fangyuan Cao & Minghui Li & Guangtian Wang & 2 2 1 4 2 Tingting Shen & Hongmin Yao & Yumei Liu & Zhenwei Pan & Shasha Song & 2,4,5,6,7 Daling Zhu Received: 17 August 2016 /Revised: 14 March 2017 /Accepted: 28 April 2017 /Published online: 7 June 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract as well as hypoxia-stimulated cell-cycle transition from the G / Abnormal pulmonary arterial smooth muscle cells (PASMCs) G phase to S phase. Subsequently, we studied the role of proliferation is an important pathological process in hypoxic microRNAs in mitochondrial function associated with pulmonary arterial hypertension. Mitochondrial dynamics and PASMC proliferation under hypoxic conditions. The promotive quality control have a central role in the maintenance of the cell effect of Mfn1 on pulmonary vascular remodeling was allevi- proliferation–apoptosis balance. However, the molecular mech- ated in the presence of miR-125a agomir, and miR-125a http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Molecular Medicine Springer Journals

MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic pulmonary vascular remodeling

Loading next page...
1
 
/lp/springer_journal/mir-125a-regulates-mitochondrial-homeostasis-through-targeting-lWni2ddQCV

References (52)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Biomedicine; Molecular Medicine; Human Genetics; Internal Medicine
ISSN
0946-2716
eISSN
1432-1440
DOI
10.1007/s00109-017-1541-5
pmid
28593577
Publisher site
See Article on Publisher Site

Abstract

J Mol Med (2017) 95:977–993 DOI 10.1007/s00109-017-1541-5 ORIGINAL ARTICLE MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic pulmonary vascular remodeling 1 2 2 2 2 Cui Ma & Chen Zhang & Mingfei Ma & Lixin Zhang & Linlin Zhang & 2 1 3 4 4 Fengying Zhang & Yingli Chen & Fangyuan Cao & Minghui Li & Guangtian Wang & 2 2 1 4 2 Tingting Shen & Hongmin Yao & Yumei Liu & Zhenwei Pan & Shasha Song & 2,4,5,6,7 Daling Zhu Received: 17 August 2016 /Revised: 14 March 2017 /Accepted: 28 April 2017 /Published online: 7 June 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract as well as hypoxia-stimulated cell-cycle transition from the G / Abnormal pulmonary arterial smooth muscle cells (PASMCs) G phase to S phase. Subsequently, we studied the role of proliferation is an important pathological process in hypoxic microRNAs in mitochondrial function associated with pulmonary arterial hypertension. Mitochondrial dynamics and PASMC proliferation under hypoxic conditions. The promotive quality control have a central role in the maintenance of the cell effect of Mfn1 on pulmonary vascular remodeling was allevi- proliferation–apoptosis balance. However, the molecular mech- ated in the presence of miR-125a agomir, and miR-125a

Journal

Journal of Molecular MedicineSpringer Journals

Published: Jun 7, 2017

There are no references for this article.